Abstract 294P
Background
Cancer patients are living longer with early detection and improved treatment. When combined with conventional therapy, complementary and alternative medicine (CAM) might help patients manage cancer symptoms and treatment toxicities. Ayurveda, Yoga Naturopathy, Unani, Siddha, and Homeopathy (AYUSH) are native to India, and widely practiced, yet, their association with cancer-related distress is unknown.
Methods
From March to June 2022, cancer patients attending OPD, IPD, and Daycare services at AIIMS Rishikesh responded to a patient health questionnaire (PHQ-9), along with a locally developed and validated questionnaire about knowledge, attitude, practices (KAP) of CAM. Bivariate and multivariate analyses were performed to ascertain the levels of depression/distress, KAP-related outcomes of CAM among cancer patients.
Results
556 cancer patients with a mean age of 48.59 ± 14.82 years (286 males, 270 females) were included. 393 respondents (70.7%) had never used CAM, while 163 (29.3%) had. 342 (61.5%) participants said they would choose CAM if their condition became untreatable, 129 (23.2%) wouldn't, 85 (15.3%) were not sure. Use of CAM was correlated with cancer stage (C 0.104, p 0.045) (ρ .098, p .020). Individuals with stage 4 cancer were more likely to have used CAM (p .029, OR 1.719, CI 1.059 ± 2.792). Multinomial linear regression showed that metastatic cancer tends to have more severe depression (p .022, OR 3.900, CI 1.218 ± 12.490). The level of education was inversely related to beliefs about CAM's effectiveness in curing cancer (C .185, p .012 & ρ -0.12, p .004) and its safety with fewer adverse reactions than modern medicine (C .197, p .004 & ρ -.124, p .003). Among AYUSH modalities, 212 (38.1%) chose Yoga, 186 (33.5%) Ayurveda, 45 (8.1%), Unani, 19 (3.4%), Siddha, and 173 (31.1%) chose others.
Conclusions
Terminally ill patients used CAM more, advanced-stage cancer patients had higher depression scores. People with lower educational status believe in CAM more.Yoga was the most preferred CAM. CAM can aid in improving cancer therapy tolerance and end-of-life care but specific CAM especially yoga protocols can be developed to help in these situations.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
303P - Long-term oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery
Presenter: Ji Hyung Hong
Session: Poster viewing 04
306P - Multimodal management and outcomes of stage III non-small cell lung cancer: KINDLE-Egypt analysis
Presenter: Rasha Aboelhassan
Session: Poster viewing 04
307P - Differential expression profiling of transcripts in stage IIIA non-small cell lung cancer (NSCLC) of smokers and non-smokers cases of north India: A geneto-environmental study
Presenter: Archana Mishra
Session: Poster viewing 04
308P - Phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Presenter: Masanao Nakashima
Session: Poster viewing 04
309P - Pneumonitis and corticosteroid treatment in patients with unresectable non-small cell lung cancer receiving durvalumab consolidation after definitive chemoradiotherapy
Presenter: Saori Murata
Session: Poster viewing 04
311P - Cost-effectiveness of alectinib compared with chemotherapy in first-line treatment for anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer in Thailand
Presenter: Sermsiri Sangroongruangsri
Session: Poster viewing 04
312P - ClinMatch: A clinical trial matching platform that improves trial accessibility among NSCLC patients through comprehensive genomic and clinical profiling
Presenter: Allen Chi Shing Yu
Session: Poster viewing 04
313P - A pool analysis of MET TKI SCC244 in NSCLC patients with MET overexpression
Presenter: Yongfeng Yu
Session: Poster viewing 04